...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Lectins, Interconnecting Proteins with Biotechnological/Pharmacological and Therapeutic Applications
【24h】

Lectins, Interconnecting Proteins with Biotechnological/Pharmacological and Therapeutic Applications

机译:凝集素,用生物技术/药理学和治疗应用互连蛋白质

获取原文
获取原文并翻译 | 示例

摘要

Lectins are proteins extensively used in biomedical applications with property to recognize carbohydrates through carbohydrate-binding sites, which identify glycans attached to cell surfaces, glycoconjugates, or free sugars, detecting abnormal cells and biomarkers related to diseases. These lectin abilities promoted interesting results in experimental treatments of immunological diseases, wounds, and cancer. Lectins obtained from virus, microorganisms, algae, animals, and plants were reported as modulators and tool markers in vivo and in vitro; these molecules also play a role in the induction of mitosis and immune responses, contributing for resolution of infections and inflammations. Lectins revealed healing effect through induction of reepithelialization and cicatrization of wounds. Some lectins have been efficient agents against virus, fungi, bacteria, and helminths at low concentrations. Lectin-mediated bioadhesion has been an interesting characteristic for development of drug delivery systems. Lectin histochemistry and lectin-based biosensors are useful to detect transformed tissues and biomarkers related to disease occurrence; antitumor lectins reported are promising for cancer therapy. Here, we address lectins from distinct sources with some biological effect and biotechnological potential in the diagnosis and therapeutic of diseases, highlighting many advances in this growing field.
机译:凝集素是蛋白质广泛用于生物医学应用中,其性质通过碳水化合物结合位点识别碳水化合物,其鉴定附着在细胞表面,糖醌或游离糖的聚糖,检测与疾病有关的异常细胞和生物标志物。这些凝集素能力促进了免疫疾病,伤口和癌症的实验治疗的有趣结果。从病毒,微生物,藻类,动物和植物中获得的凝集素作为调节剂和体内和体外工具标记物报告;这些分子在诱导有丝分裂和免疫应答中起作用作用,有助于解决感染和炎症。凝集素通过诱导伤口的重热化和瘢痕化而揭示了愈合效果。一些章节已经有效药物免受病毒,真菌,细菌和低浓度的蠕虫。介相介导的生物粘度是药物递送系统的发展是一种有趣的特征。凝集素组织化学和凝集素的生物传感器可用于检测与疾病发生相关的转化组织和生物标志物;报告的抗肿瘤凝集素是对癌症治疗有前途的。在这里,我们在疾病的诊断和治疗中与不同来源的凝集素进行了一些生物效应和生物技术潜力,突出了这一生长领域的许多进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号